Shay Capital »

Nuvectis Pharma shares owned by Shay Capital

Quarter-by-quarter ownership of Nuvectis Pharma (NVCT) shares owned by Shay Capital from 13F filings

Historical chart of Shay Capital investment in Nuvectis Pharma

Tip: Access up to 7 years of quarterly data

All positions including Nuvectis Pharma held by Shay Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvectis Pharma by Shay Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $386k 21k 18.39

More positions owned by Shay Capital

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Take-Two Interactive Software (TTWO)
Ftai Aviation SHS (FTAI)
Purecycle Technologies (PCT)
Corecivic (CXW)
Ishares Tr Russell 2000 Etf (IWM)
Meta Platforms Cl A (META)
Baidu Spon Adr Rep A (BIDU)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Celsius Hldgs Com New (CELH)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Honeywell International (HON)
Golar Lng SHS (GLNG)
Papa John's Int'l (PZZA)

View all positions for Shay Capital

Top funds holding Nuvectis Pharma

Tang Capital Management
BlackRock
Soleus Capital Management
Perceptive Advisors
Vanguard Capital Management
Iridian Asset Management
Geode Capital Management
Sphera Funds Management
Baldwin Brothers
Occam Crest Management
Susquehanna International
Alyeska Investment Group
Avidity Partners Management
Citadel Advisors
State Street Corporation

View all funds holding Nuvectis Pharma